Related Experiment Video
Updated: Feb 27, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Mortality trends for multiple sclerosis patients in Sweden from 1968 to 2012
Sarah Burkill1, Scott Montgomery2, MohammadHossein Hajiebrahimi2
1From the Clinical Epidemiology Unit (S.B., S.M., M.H., S.B) and Centre for Pharmacoepidemiology (S.B., S.B.), Department of Medicine, Solna, Karolinska Institutet, Stockholm; Clinical Epidemiology and Biostatistics (S.M.), School of Medical Sciences, Örebro University, Sweden; Department of Epidemiology and Public Health (S.M.), University College London, UK; Division of Neurology (J.H.) and Neuroimmunology Unit (T.O.), Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; and Biostatistics and Epidemiology Unit (M.H., S.B.), Health Faculty, Golestan University of Medical Sciences, Golestan, Iran. Sarah.Burkill@ki.se.
Objective:
To assess trends in mortality and causes of death for patients with multiple sclerosis (MS) relative to those without MS in Sweden.
Methods:
Patients with an MS diagnosis in Sweden between 1964 and 2012 were identified with the Patient Register and the Multiple Sclerosis Register. For this cohort study, each patient with MS (n = 29,617) was matched with 10 individuals without MS (n = 296,164) on sex, year of birth, vital status, and region of residence at the time of MS diagnosis with the Total Population Register. The Causes of Death Register was used to identify causes of death. Cox proportional hazard models were constructed to assess whether risk of mortality was increased for patients with MS.
Results:
The hazard ratio (HR) for patients with MS was 2.92 (95% confidence interval [CI] 2.86-2.99) for all-cause mortality over the entire study period. The largest differences between the cohorts were death resulting from respiratory (HR 5.07, 95% CI 4.87-5.26) and infectious (HR 4.07, 95% CI 3.70-4.47) diseases. Overall and for each specific cause, there have been improvements for the MS group and a subsequent reduction in the HR. The HR decreased from 6.52 (95% CI 5.79-7.34) for the period of 1968 to 1980 to 2.08 (95% CI 1.95-2.22) for the time period of 2001 to 2012. An interaction between time period and MS exposure showed that the decrease in mortality over time was statistically significant, with a larger decrease for patients with MS than their matched comparators.
Conclusions:
There has been a substantial improvement in mortality overall and for each specified cause of death for patients with MS compared with individuals without MS; however, large differences still remain.
Insights
Mortality for multiple sclerosis (MS) patients significantly decreased over time, showing substantial improvements in survival rates. However, individuals with MS still face higher mortality risks compared to the general population.
Area of Science:
- Neurology
- Epidemiology
- Public Health
Background:
- Multiple sclerosis (MS) is a chronic neurological disease with significant impact on patient mortality.
- Understanding mortality trends in MS is crucial for improving patient care and public health strategies.
Purpose of the Study:
- To analyze mortality trends and causes of death in patients with multiple sclerosis (MS) in Sweden.
- To compare mortality rates between individuals with MS and matched controls without MS.
Main Methods:
- A Swedish cohort study identified 29,617 patients with MS (1964-2012) and matched them with 296,164 controls.
- Cox proportional hazard models were used to assess mortality risk in the MS cohort.
- Data on causes of death were obtained from the Causes of Death Register.
Main Results:
- Patients with MS had a 2.92-fold increased risk of all-cause mortality compared to controls.
- Respiratory and infectious diseases showed the largest mortality differences (HR 5.07 and 4.07, respectively).
- Mortality risk for MS patients significantly decreased over time, with hazard ratios reducing from 6.52 (1968-1980) to 2.08 (2001-2012).
Conclusions:
- Substantial improvements in survival have been observed for patients with MS, with significant reductions in mortality across various causes.
- Despite these improvements, individuals with MS continue to experience higher mortality rates than the general population.
- Further research and interventions are needed to address the remaining mortality disparities.
Related Concept Videos
Longitudinal Research
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Cancer Survival Analysis
Life Tables
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Assumptions of Survival Analysis

